1. Antignani PL. Medical Treatment of Chronic Venous Disease. Sm J Pharmac Ther. 2017; 3(1):1015.
2. Pascarella L, Schonbein GW, Bergan JJ. Microcirculation and Venous Ulcers: a review. Annals of Vascular Surgery. Doi : 10.1007/s10016-005-7661-3
3. Ulloa,JH. Micronized Purified Flavonoid Fraction (MPFF) for Patients Suffering from Chronic Venous Disease: A Review of New Evidence. Advances in Therapy volume 36, pages20–25(2019). https://link.springer.com/article/10.1007/s12325-019-0884-4
4. Coleridge Smith PD. From skin disorders to venous leg ulcers: pathophysiology and efficacy of Daflon 500 mg in ulcer healing. Angiology. 2003 Jul-Aug;54 Suppl 1:S45-50. https://www.ncbi.nlm.nih.gov/pubmed/12934756
5. Kakkos SK and Nicolaides AN. Efficacy of micronized purified flavonoid fraction (Daflon®) on improving individual symptoms, signs and quality of life in patients with chronic venous disease: a systematic review and meta-analysis of randomized double-blind placebo-controlled trials. Int Angiol. 2018 Apr;37(2):143-154. https://www.ncbi.nlm.nih.gov/pubmed/29385792
6. Lyseng-Williamson KA and Perry CM. Micronised purified flavonoid fraction: a review of its use in chronic venous insufficiency, venous ulcers and haemorrhoids. Drugs. 2003;63(1):71-100. https://www.ncbi.nlm.nih.gov/pubmed/12487623
7. Mansilha, Armando and Sousa, Joel. Pathophysiological Mechanisms of Chronic Venous Disease and Implications for Venoactive Drug Therapy. Int J Mol Sci. 2018;19(6):1669. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032391/
8. Katsenis, K. Micronized purified flavonoid fraction (MPFF): a review of its pharmacological effects, therapeutic efficacy and benefits in the management of chronic venous insufficiency. Curr Vasc Pharmacol. 2005 Jan;3(1):1-9. https://www.ncbi.nlm.nih.gov/pubmed/15641940
9. Ramelet AA. Clinical benefits of Daflon 500 mg in the most severe stages of chronic venous insufficiency. Angiology. 2001 Aug;52 Suppl 1:S49-56. https://www.ncbi.nlm.nih.gov/pubmed/11510597
10. Gavrilov, SG et al. Effectiveness and safety of micronized purified flavonoid fraction for the treatment of concomitant varicose veins of the pelvis and lower extremities. Curr Med Res Opin. 2019 Jun;35(6):1019-1026. https://www.ncbi.nlm.nih.gov/pubmed/30468077
11. de Souza Md, Cyrino FZ, Mayall MR, Virgini-Magalhães CE, Sicuro FL, de Carvalho JJ, Verbeuren TJ, Bouskela E. Beneficial effects of the micronized purified flavonoid fraction (MPFF, Daflon® 500 mg) on microvascular damage elicited by sclerotherapy. Phlebology. 2016 Feb;31(1):50-6. doi: 10.1177/0268355514564414. Epub 2014 Dec 15. PMID: 25514922.
12. Milano, G., Leone, S., Fucile, C. et al. Uncommon serum creatine phosphokinase and lactic dehydrogenase increase during diosmin therapy: two case reports. J Med Case Reports 8, 194 (2014). https://doi.org/10.1186/1752-1947-8-194
13. Raetz J, Wilson M, Collins K. Varicose Vein : Diagnosis and Treatment. Am Fam Physician. 2019 Jun 1;99(11):682-688.
14. O'Flynn, N., Vaughan, M., & Kelley, K. (2014). Diagnosis and management of varicose veins in the legs: NICE guideline. The British journal of general practice : the journal of the Royal College of General Practitioners, 64(623), 314–315. doi:10.3399/bjgp14X680329.